Michael Deppe Biography and Net Worth



Michael J. Deppe is the VP, Corp. Controller & Chief Accounting Officer at Quest Diagnostics.

What is Michael J. Deppe's net worth?

The estimated net worth of Michael J. Deppe is at least $5.35 million as of November 6th, 2024. Mr. Deppe owns 34,941 shares of Quest Diagnostics stock worth more than $5,349,467 as of December 22nd. This net worth approximation does not reflect any other investments that Mr. Deppe may own. Learn More about Michael J. Deppe's net worth.

How old is Michael J. Deppe?

Mr. Deppe is currently 57 years old. There are 5 older executives and no younger executives at Quest Diagnostics. The oldest executive at Quest Diagnostics is Mr. Michael E. Prevoznik, Senior VP & General Counsel, who is 62 years old. Learn More on Michael J. Deppe's age.

How do I contact Michael J. Deppe?

The corporate mailing address for Mr. Deppe and other Quest Diagnostics executives is 500 PLAZA DRIVE, SECAUCUS NJ, 07094. Quest Diagnostics can also be reached via phone at (973) 520-2700 and via email at [email protected]. Learn More on Michael J. Deppe's contact information.

Has Michael J. Deppe been buying or selling shares of Quest Diagnostics?

During the past quarter, Michael J. Deppe has sold $2,889,207.75 of Quest Diagnostics stock. Most recently, Michael J. Deppe sold 18,755 shares of the business's stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $154.05, for a transaction totalling $2,889,207.75. Following the completion of the sale, the chief accounting officer now directly owns 34,941 shares of the company's stock, valued at $5,382,661.05. Learn More on Michael J. Deppe's trading history.

Who are Quest Diagnostics' active insiders?

Quest Diagnostics' insider roster includes Mark Delaney (SVP), Michael Deppe (CAO), Catherine Doherty (SVP), Vicky Gregg (Director), Mark Guinan (CFO), Karthik Kuppusamy (SVP), Michael Prevoznik (SVP), Timothy Ring (Director), Stephen Rusckowski (CEO), Daniel Stanzione (Director), and Gail Wilensky (Director). Learn More on Quest Diagnostics' active insiders.

Are insiders buying or selling shares of Quest Diagnostics?

In the last twelve months, insiders at the medical research company sold shares 10 times. They sold a total of 39,850 shares worth more than $5,692,423.40. The most recent insider tranaction occured on November, 6th when CAO Michael J Deppe sold 18,755 shares worth more than $2,889,207.75. Insiders at Quest Diagnostics own 0.8% of the company. Learn More about insider trades at Quest Diagnostics.

Information on this page was last updated on 11/6/2024.

Michael J. Deppe Insider Trading History at Quest Diagnostics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/6/2024Sell18,755$154.05$2,889,207.7534,941View SEC Filing Icon  
10/26/2022Sell15,497$145.00$2,247,065.0032,013View SEC Filing Icon  
10/21/2020Sell10,450$125.00$1,306,250.0029,785View SEC Filing Icon  
9/17/2019Sell5,000$106.00$530,000.0028,671View SEC Filing Icon  
See Full Table

Michael J. Deppe Buying and Selling Activity at Quest Diagnostics

This chart shows Michael J Deppe's buying and selling at Quest Diagnostics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Quest Diagnostics Company Overview

Quest Diagnostics logo
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Read More

Today's Range

Now: $153.10
Low: $151.68
High: $154.10

50 Day Range

MA: $157.03
Low: $147.40
High: $164.19

2 Week Range

Now: $153.10
Low: $123.04
High: $165.32

Volume

1,344,317 shs

Average Volume

917,121 shs

Market Capitalization

$17.09 billion

P/E Ratio

20.58

Dividend Yield

1.98%

Beta

0.89